Snowball logo
logo
PHAR

Pharming Group NV

$11.90+$0.70Β  (6.25%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
198.9205.6245.3297.2376.1366.4
COGS
21.1417.5625.2135.445.549.36
Gross Profit
177.7188.1220.1261.8330.6317.1
Operating Expenses & Income
Operating Income
19.019.86(22.29)(3.665)20.8812.35
Total Operating Expenses
158.7178.2242.4265.5309.8304.7
R&D Expenses
70.3752.5368.9183.15100.4113.3
Selling General & Admin Expenses
52.5862.4480.6892.08110.867.12
Earnings from Continuing Operations
Interest Expense
(7.001018)(5.358)(5.964)(9.047076)(10.72)(14.72)
Interest Income
12.570.0853.6634.8582.1765.143
Income Tax Expense
7.0821.313(1.464)3.34910.316.569
Net Income
Net Income
1613.67(10.55)(11.84)2.8519.273
Supplemental
EBIT
29.1720.34(6.048)0.24523.5730.56
EBITDA
48.7833.539.87716.3234.7842.65
In millions of USD, except % and values per 1 share